Mode
Text Size
Log in / Sign up
N/A N=15 Randomized Treatment

Acupressure in Pruritus for Atopic Dermatitis

Atopic Dermatitis

Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Jan 2013
Primary outcome: Primary: Change in Itch Intensity as Measured by a Change in Visual Analog Scale (VAS) Score — 0.8; -5.0 centimeters

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Standard-of-care treatment for AD (Other); Accu-patch pellet (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Northwestern University
Primary completion
Dec 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Itch Intensity as Measured by a Change in Visual Analog Scale (VAS) Score
0.8; -5.0
SECONDARY
Change in Severity of Atopic Dermatitis (AD) as Measured by a Change in Investigator Global Assessment (IGA) Score
0.5; -1
SECONDARY
Change in Severity of Atopic Dermatitis (AD) as Measured by a Change in Eczema Area and Severity Index (EASI): Area Subscale Score
0; -1
SECONDARY
Change in Severity of Atopic Dermatitis (AD) as Measured by a Change in Eczema Area and Severity Index (EASI): Erythema Subscale Score
0; -1
SECONDARY
Change in Severity of Atopic Dermatitis (AD) as Measured by a Change in Eczema Area and Severity Index (EASI): Infiltration/Papulation Subscale Score
0; -1
SECONDARY
Change in Severity of Atopic Dermatitis (AD) as Measured by a Change in Eczema Area and Severity Index (EASI): Excoriation Subscale Score
0; -1
SECONDARY
Change in Severity of Atopic Dermatitis (AD) as Measured by a Change in Eczema Area and Severity Index (EASI): Lichenification Subscale Score
0; -1

Summary

The purpose of this study is to see if acupressure will be effective at reducing itch in people with atopic dermatitis (AD).

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of AD by dermatologist
  • Not currently using acupressure or acupuncture for treatment of AD
  • Able to read, write, and understand study materials
  • Age 18 or older

Exclusion Criteria

  • Unable to physically perform acupressure technique
  • Significant comorbidities causing itch such as chronic urticaria, renal failure, notalgia paresthetica, and tinea
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01074164). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search